High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up

Okamoto, Satoko; Chen, Shu-Tian; Covelli, James; DeMartini, Wendy B.; Daniel, Bruce L.; Ikeda, Debra M.

doi:10.1007/s12282-019-01032-8

Cited by 20 publications

(10 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ferreira et al [ 42 ] indicated lower upgrade rates of RS with greater number of fragments obtained at biopsy and in RS subjected to VAB than in those subjected to core biopsy. In a recent study, Okamoto et al [ 67 ] stated that when MRI biopsy is vacuum assisted, the risk of upgrade and malignancy is significantly lower with less indication for excisional biopsy.…”

Section: Managementmentioning

confidence: 99%

Radial Scar: a management dilemma

et al. 2021

View full text Add to dashboard Cite

Radial scar (RS) or complex sclerosing lesions (CSL) if > 10 mm is a benign lesion with an increasing incidence of diagnosis (ranging from 0.6 to 3.7%) and represents a challenge both for radiologists and for pathologists. The digital mammography and digital breast tomosynthesis appearances of RS are well documented, according to the literature. On ultrasound, variable aspects can be detected. Magnetic resonance imaging contribution to differential diagnosis with carcinoma is growing. As for the management, a vacuum-assisted biopsy (VAB) with large core is recommended after a percutaneous diagnosis of RS due to potential sampling error. According to the recent International Consensus Conference, a RS/CSL lesion, which is visible on imaging, should undergo therapeutic excision with VAB. Thereafter, surveillance is justified. The aim of this review is to provide a practical guide for the recognition of RS on imaging, illustrating radiological findings according to the most recent literature, and to delineate the management strategies that follow.

show abstract

Section: Managementmentioning

confidence: 99%

Radial Scar: a management dilemma

et al. 2021

View full text Add to dashboard Cite

show abstract

“…4 Regrettably, it is not effective in detecting lesions in dense breasts. Other technologies, such as magnetic resonance imaging (MRI), 5 ultrasound, 6 imaging test technology, 7 and breast biopsy, 8 are also commonly used in the diagnosis of breast cancer. These methods are very effective and can detect 80%-90% of breast cancer cases, but they also have some limitations.…”

Section: Introductionmentioning

confidence: 99%

Preparation of bimetal–polydopamine organic frameworks with core–shell structure and their application in HER2 detection

Chen

Hou

et al. 2022

Analyst

View full text Add to dashboard Cite

show abstract

“…The key issue is that the management of these lesions is highly controversial and is therefore the center of a lively debate, that could be fittingly approached by building evidence from large series, which are still sporadically available [ 14 , 15 , 16 ]. If performed with large-caliber needles, VAB seems to consistently improve lesion characterization in B3 lesions [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ], even assuming a therapeutic role with vacuum-assisted excision, which is increasingly being proposed with interesting results [ 25 , 26 , 27 , 28 ].…”

Section: Introductionmentioning

confidence: 99%

B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies

Girardi

Guaragni

Ruzzenenti

et al. 2021

Cancers

View full text Add to dashboard Cite

The rate of upgrade to cancer for breast lesions with uncertain malignant potential (B3 lesions) diagnosed at needle biopsy is highly influenced by several factors, but large series are seldom available. We retrospectively assessed the upgrade rates of a consecutive series of B3 lesions diagnosed at ultrasound- or mammography-guided vacuum-assisted biopsy (VAB) at an EUSOMA-certified Breast Unit over a 7-year timeframe. The upgrade rate was defined as the number of ductal carcinoma in situ (DCIS) or invasive cancer at pathology after excision or during follow-up divided by the total number of B3 lesions. All lesions were reviewed by one of four pathologists with a second opinion for discordant assessments of borderline cases. Excision or surveillance were defined by the multidisciplinary tumor board, with 6- and 12-month follow-up. Out of 3634 VABs (63% ultrasound-guided), 604 (17%) yielded a B3 lesion. After excision, 17/604 B3 lesions were finally upgraded to malignancy (2.8%, 95% confidence interval [CI] 1.8–4.5%), 10/17 (59%) being upgraded to DCIS and 7/17 (41%) to invasive carcinoma. No cases were upgraded during follow-up. B3a lesions showed a significantly lower upgrade rate (0.4%, 95% CI 0.1–2.1%) than B3b lesions (4.7%, 95% CI 2.9–7.5%, p = 0.001), that had a 22.0 adjusted odds ratio for upgrade (95% CI 2.1–232.3). No significant difference was found in upgrade rates according to imaging guidance or needle caliper. Surveillance-oriented management can be considered for B3a lesions, while surgical excision should be pursued for B3b lesions.

show abstract

High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up

Cited by 20 publications

References 36 publications

Radial Scar: a management dilemma

Radial Scar: a management dilemma

Preparation of bimetal–polydopamine organic frameworks with core–shell structure and their application in HER2 detection

B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies

Contact Info

Product

Resources

About